Taguchi S[au] - Search Results

Year	Number of Results
1963	1
1965	1
1966	3
1967	1
1968	4
1970	3
1971	2
1972	2
1973	2
1974	9
1975	1
1977	2
1979	3
1980	2
1981	7
1982	7
1983	8
1984	2
1985	6
1986	7
1987	4
1988	8
1989	7
1990	6
1991	8
1992	7
1993	12
1994	14
1995	11
1996	12
1997	13
1998	11
1999	8
2000	11
2001	15
2002	20
2003	26
2004	25
2005	18
2006	26
2007	23
2008	23
2009	29
2010	31
2011	28
2012	26
2013	31
2014	21
2015	34
2016	24
2017	32
2018	33
2019	28
2020	48
2021	45
2022	24

1

Oncolytic virus therapy in Japan: progress in clinical trials and future perspectives.

Taguchi S, Fukuhara H, Todo T. Taguchi S, et al. Jpn J Clin Oncol. 2019 Mar 1;49(3):201-209. doi: 10.1093/jjco/hyy170. Jpn J Clin Oncol. 2019. PMID: 30462296 Review.

2

[Mucositis].

Sato A, Sakashita A, Taguchi S. Sato A, et al. Among authors: taguchi s. Nihon Rinsho. 2003 Jun;61(6):959-65. Nihon Rinsho. 2003. PMID: 12806943 Review. Japanese.

3

MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo.

Hirai H, Sootome H, Nakatsuru Y, Miyama K, Taguchi S, Tsujioka K, Ueno Y, Hatch H, Majumder PK, Pan BS, Kotani H. Hirai H, et al. Among authors: taguchi s. Mol Cancer Ther. 2010 Jul;9(7):1956-67. doi: 10.1158/1535-7163.MCT-09-1012. Epub 2010 Jun 22. Mol Cancer Ther. 2010. PMID: 20571069

4

Primary cardiac solitary fibrous tumors.

Taguchi S. Taguchi S. Ann Thorac Cardiovasc Surg. 2015;21(4):329-31. doi: 10.5761/atcs.ra.15-00193. Epub 2015 Jul 7. Ann Thorac Cardiovasc Surg. 2015. PMID: 26156195 Free PMC article. Review.

5

Inconsistencies in currently used definitions of sarcopenia in oncology.

Taguchi S, Nakagawa T, Fukuhara H. Taguchi S, et al. Ann Oncol. 2020 Feb;31(2):318-319. doi: 10.1016/j.annonc.2019.10.020. Epub 2019 Dec 4. Ann Oncol. 2020. PMID: 31959350 Free article. No abstract available.

6

Advances and needs for endotoxin-free production strains.

Taguchi S, Ooi T, Mizuno K, Matsusaki H. Taguchi S, et al. Appl Microbiol Biotechnol. 2015 Nov;99(22):9349-60. doi: 10.1007/s00253-015-6947-9. Epub 2015 Sep 11. Appl Microbiol Biotechnol. 2015. PMID: 26362682 Review.

7

Surgery for primary intrapericardial tumors in adults.

Taguchi S, Yozu R. Taguchi S, et al. J Card Surg. 2013 Sep;28(5):529-32. doi: 10.1111/jocs.12164. Epub 2013 Jun 30. J Card Surg. 2013. PMID: 23808619 Review.

8

Immuno-checkpoint inhibitor-associated hyper-eosinophilia and tumor shrinkage.

Osawa H, Okauchi S, Taguchi S, Kagohashi K, Satoh H. Osawa H, et al. Among authors: taguchi s. Tuberk Toraks. 2018 Mar;66(1):80-83. doi: 10.5578/tt.66667. Tuberk Toraks. 2018. PMID: 30020049 Free article. English. No abstract available.

9

PHA synthase engineering toward superbiocatalysts for custom-made biopolymers.

Nomura CT, Taguchi S. Nomura CT, et al. Among authors: taguchi s. Appl Microbiol Biotechnol. 2007 Jan;73(5):969-79. doi: 10.1007/s00253-006-0566-4. Epub 2006 Nov 23. Appl Microbiol Biotechnol. 2007. PMID: 17123079 Review.

10

Localized bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor treatment.

Oya K, Fujii M, Taguchi S, Nishie W, Izumi K, Shimizu H. Oya K, et al. Among authors: taguchi s. Eur J Dermatol. 2018 Apr 1;28(2):250-251. doi: 10.1684/ejd.2018.3230. Eur J Dermatol. 2018. PMID: 29400293 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results